Selskabets formål er at udvikle software og yde konsulentassistance.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 5.1 mio. | -925 t. | 5.3 mio. | 1.8 mio. | 9 | |
CVR: 39085127
Compared to 6.247 companies in Computerkonsulentbistand og forvaltning af computerfaciliteter
Comparison is based on industry median values
The financial health of Raven biosciences ApS appears to be declining, as evidenced by a significant drop in revenue from 12.67 million DKK in 2022 to 5.1 million DKK in 2024, alongside a loss of 925,200 DKK in profit for the same year. The company has experienced fluctuating profitability, with a peak profit of 2.48 million DKK in 2022 followed by a loss in 2024. Equity has also decreased from 3.92 million DKK in 2023 to 1.8 million DKK in 2024, raising concerns about its financial stability. Overall, the company is facing challenges in maintaining its position within the computer consulting and facility management industry, indicating a need for strategic adjustments to reverse its current trajectory.
AI-generated summary
Companies in the same industry and area
companydata.dk